We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+15.45%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$201B
AUM Growth
+$18.3B
Cap. Flow
-$12.7B
Cap. Flow %
-6.33%
Top 10 Hldgs %
24.23%
Holding
10,449
New
1,430
Increased
3,737
Reduced
3,810
Closed
1,252

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$415M
2
LLY icon
Eli Lilly
LLY
+$402M
3
GS icon
Goldman Sachs
GS
+$384M
4
MCD icon
McDonald's
MCD
+$379M
5
TSLA icon
Tesla
TSLA
+$304M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.98B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$596M
3
T icon
AT&T
T
+$460M
4
SYF icon
Synchrony
SYF
+$398M
5
HON icon
Honeywell
HON
+$342M

Sector Composition

Rank Sector Weight
1 Technology 5.53%
2 Financials 4.78%
3 Healthcare 3.89%
4 Industrials 3.6%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENE
8826
DELISTED
Genetic Technologies Ltd.
GENE
$29K ﹤0.01%
1,639
-59
-3% -$979
SQBG
8827
DELISTED
Sequential Brands Group, Inc.
SQBG
$29K ﹤0.01%
+563
New +$25.6K
AMR
8828
DELISTED
Alta Mesa Resources Inc
AMR
$29K ﹤0.01%
107,966
-1,021,152
-90% -$773K
BMRA icon
8829
Biomerica
BMRA
$4.6M
$28K ﹤0.01%
+1,406
New +$27.4K
DAC icon
8830
Danaos Corp
DAC
$2.58B
$28K ﹤0.01%
+2,281
New +$28.9K
PLUR icon
8831
CALL
Pluri
PLUR
$16.7M
$28K ﹤0.01%
361
-132
-27% -$10.9K
RNTX
8832
Rein Therapeutics
RNTX
$63.1M
$28K ﹤0.01%
713
-313
-31% -$9.75K
CBK
8833
DELISTED
Christopher & Banks Corporation
CBK
$28K ﹤0.01%
81,546
+62,328
+324% +$32.4K
MLSS icon
8834
Milestone Scientific
MLSS
$35.3M
$27K ﹤0.01%
80,914
+53,592
+196% +$19.7K
FLNA
8835
Filana Therapeutics
FLNA
$48.8M
$27K ﹤0.01%
+20,731
New +$23.8K
UPL
8836
CALL
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$27K ﹤0.01%
43,600
-2,200
-5% -$1.6K
MARK
8837
DELISTED
Remark Holdings, Inc.
MARK
$26K ﹤0.01%
1,381
-261
-16% -$5.31K
NYMX
8838
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$26K ﹤0.01%
13,300
-6,900
-34% -$14.6K
DTEA
8839
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$26K ﹤0.01%
19,190
-19,914
-51% -$28.1K
IDXG
8840
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$26K ﹤0.01%
+3,262
New +$30.7K
FCSC
8841
DELISTED
Fibrocell Science Inc.
FCSC
$26K ﹤0.01%
13,525
-16,401
-55% -$32.6K
TAT
8842
DELISTED
TransAtlantic Petroleum LTD.
TAT
$26K ﹤0.01%
30,031
+16,510
+122% +$18.9K
DXLG icon
8843
Destination XL Group
DXLG
$31.2M
$25K ﹤0.01%
10,214
-3,117
-23% -$7.8K
EMX
8844
DELISTED
EMX Royalty
EMX
$25K ﹤0.01%
+21,411
New +$25.3K
MVIS icon
8845
PUT
Microvision
MVIS
$6.21M
$25K ﹤0.01%
+26,000
New +$25.1K
VEON icon
8846
PUT
VEON
VEON
$3.62B
$25K ﹤0.01%
480
-2,500
-84% -$156K
VGZ icon
8847
CALL
Vista Gold
VGZ
$251M
$25K ﹤0.01%
36,300
-21,600
-37% -$15K
QUMU
8848
DELISTED
Qumu Corp.
QUMU
$25K ﹤0.01%
10,302
+69
+0.7% +$158
ARCW
8849
DELISTED
ARC Group Worldwide, Inc
ARCW
$25K ﹤0.01%
27,498
+17,074
+164% +$16.7K
DYY
8850
DELISTED
DB Commodity Double Long ETN due April 1, 2038
DYY
$25K ﹤0.01%
11,200
-562
-5% -$1.24K

Similar funds

Citadel Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Citadel Advisors held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $12.7B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Citadel Advisors opened a new position in Elanco Animal Health worth $251M.

  • Citadel Advisors's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
  • Citadel Advisors added most to Walt Disney in Q1 2019, an estimated $415M increase.
  • Citadel Advisors's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
  • Citadel Advisors fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
  • Citadel Advisors's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
  • Citadel Advisors opened 1,430 new positions and closed 1,252 in Q1 2019.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $201B.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.